These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 2949286)
21. Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients. Vázquez L; Encinas MP; Morín LS; Vilches P; Gutiérrez N; García-Sanz R; Caballero D; Hurlé AD Haematologica; 1999 Mar; 84(3):231-6. PubMed ID: 10189388 [TBL] [Abstract][Full Text] [Related]
22. Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients. Hamidah A; Rizal AM; Nordiah AJ; Jamal R Singapore Med J; 2008 Jan; 49(1):26-30. PubMed ID: 18204765 [TBL] [Abstract][Full Text] [Related]
23. Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis. Martino P; Micozzi A; Gentile G; Raccah R; Girmenia C; Mandelli F Clin Infect Dis; 1992 Aug; 15(2):290-4. PubMed ID: 1387806 [TBL] [Abstract][Full Text] [Related]
24. Combination of amikacin and either ampicillin or cephalotin as initial treatment of febrile neutropenic patients. Palmblad J; Lönnqvist B Acta Med Scand; 1982; 212(6):379-84. PubMed ID: 6760676 [TBL] [Abstract][Full Text] [Related]
25. Cefotaxime plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with hematologic malignancies. Martino P; Venditti M; Petti MC; Mandelli F; Serra P Infection; 1985; 13(3):125-9. PubMed ID: 3928495 [TBL] [Abstract][Full Text] [Related]
26. Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies. Yildirim I; Aytac S; Ceyhan M; Cetin M; Tuncer M; Cengiz AB; Secmeer G; Yetgin S Pediatr Hematol Oncol; 2008 Jun; 25(4):291-9. PubMed ID: 18484473 [TBL] [Abstract][Full Text] [Related]
27. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children. Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of azlocillin-amikacin combination for empirical therapy of infection in febrile neutropenic patients. D'Antonio D; di Girolamo A; Iacone A; Fioritoni G; Angelini A; Dragani A; Betti S; Dell'Isola M; Piccolomini R J Chemother; 1989 Dec; 1(6):407-12. PubMed ID: 2693624 [TBL] [Abstract][Full Text] [Related]
29. Ceftriaxone and amikacin as single daily dose in the empiric therapy for febrile episodes in neutropenic patients. Martino P; Girmenia C; Raccah R; Micozzi A; Cimino G; Mandelli F Haematologica; 1990; 75(1):69-74. PubMed ID: 2338290 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of amikacin and ticarcillin as empiric therapy in febrile neutropenic children with cancer. Faden HS; Deshpande GN; Grossi M; Surgalla M; Ettinger LJ; Freeman AI Med Pediatr Oncol; 1981; 9(5):501-9. PubMed ID: 7300805 [TBL] [Abstract][Full Text] [Related]
31. [Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients]. Sampi K; Kumai R; Maseki N; Sakurai M; Kaneko Y; Hattori M Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):674-9. PubMed ID: 3469935 [TBL] [Abstract][Full Text] [Related]
32. Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patients. Jones P; Rolston K; Fainstein V; Elting L; Bodey GP Rev Infect Dis; 1985; 7 Suppl 4():S741-6. PubMed ID: 3909332 [TBL] [Abstract][Full Text] [Related]
33. Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients. Winston DJ; Ho WG; Young LS; Hewitt WL; Gale RP Arch Intern Med; 1982 Sep; 142(9):1663-7. PubMed ID: 6214228 [TBL] [Abstract][Full Text] [Related]
34. Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors. Düzova A; Kutluk T; Kanra G; Büyükpamukçu M; Akyüz C; Seçmeer G; Ceyhan M Turk J Pediatr; 2001; 43(2):105-9. PubMed ID: 11432485 [TBL] [Abstract][Full Text] [Related]
35. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. Shenep JL; Hughes WT; Roberson PK; Blankenship KR; Baker DK; Meyer WH; Gigliotti F; Sixbey JW; Santana VM; Feldman S N Engl J Med; 1988 Oct; 319(16):1053-8. PubMed ID: 3050517 [TBL] [Abstract][Full Text] [Related]
36. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group. J Infect Dis; 1991 May; 163(5):951-8. PubMed ID: 2019772 [TBL] [Abstract][Full Text] [Related]
37. Piperacillin and netilmicin combination therapy for febrile episodes in neutropenic patients. Herbrecht R; Damonte JC; Bergerat JP; Jehl F; Liu KL; Prevost G; Dufour P; Duclos B; Oberling F Infection; 1990; 18(5):310-3. PubMed ID: 2276828 [TBL] [Abstract][Full Text] [Related]
38. Amikacin therapy of infections in neutropenic patients. Valdivieso M; Feld R; Rodriguez V; Bodey GP Am J Med Sci; 1975; 270(3):453-63. PubMed ID: 1108649 [TBL] [Abstract][Full Text] [Related]
39. Aztreonam therapy in neutropenic patients with cancer. Jones PG; Rolston KV; Fainstein V; Elting L; Walters RS; Bodey GP Am J Med; 1986 Aug; 81(2):243-8. PubMed ID: 3526885 [TBL] [Abstract][Full Text] [Related]
40. [Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy]. Kattan J; Droz JP; Culine S; Ribrag V; Boutan-Laroze A; Andremont A Bull Cancer; 1992; 79(7):705-12. PubMed ID: 1467596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]